Cited by 26Glycosylation and Glycoproteins ResearchCarbohydrate Chemistry and SynthesisProteoglycans and glycosaminoglycans research

Identification of Key Functional Residues in the Active Site of Human β1,4-Galactosyltransferase 7

Open access
Talhaoui, Ibtissam, Bui, Catherine, Oriol, Rafael, Mulliert, Guillermo, Gulberti, Sandrine, Netter, Patrick, Coughtrie, Michael W.H., Ouzzine, Mohamed +1 more·2010·Journal of Biological Chemistry

Abstract

Glycosaminoglycans (GAGs) play a central role in many pathophysiological events, and exogenous xyloside substrates of β1,4-galactosyltransferase 7 (β4GalT7), a major enzyme of GAG biosynthesis, have interesting biomedical applications. To predict functional peptide regions important for substrate binding and activity of human β4GalT7, we conducted a phylogenetic analysis of the β1,4-galactosyltransferase family and generated a molecular model using the x-ray structure of Drosophila β4GalT7-UDP as template. Two evolutionary conserved motifs, (163)DVD(165) and (221)FWGWGREDDE(230), are central in the organization of the enzyme active site. This model was challenged by systematic engineering of point mutations, combined with in vitro and ex vivo functional assays. Investigation of the kinetic properties of purified recombinant wild-type β4GalT7 and selected mutants identified Trp(224) as a key residue governing both donor and acceptor substrate binding. Our results also suggested the involvement of the canonical carboxylate residue Asp(228) acting as general base in the reaction catalyzed by human β4GalT7. Importantly, ex vivo functional tests demonstrated that regulation of GAG synthesis is highly responsive to modification of these key active site amino acids. Interestingly, engineering mutants at position 224 allowed us to modify the affinity and to modulate the specificity of human β4GalT7 toward UDP-sugars and xyloside acceptors. Furthermore, the W224H mutant was able to sustain decorin GAG chain substitution but not GAG synthesis from exogenously added xyloside. Altogether, this study provides novel insight into human β4GalT7 active site functional domains, allowing manipulation of this enzyme critical for the regulation of GAG synthesis. A better understanding of the mechanism underlying GAG assembly paves the way toward GAG-based therapeutics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m110.151951

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Biochemical methods to assess GAG synthesis in patients' cultured fibroblasts are currently available in many specialized laboratories.

    “For definite proof of GAG deficiency ( B4GALT7 and B3GALT6 mutations), biochemical methods to assess GAG synthesis in patients ' cultured fibroblasts are currently available in many specialized laboratories [Talhaoui et al., 2010].”

    From The 2017 international classification of the Ehlers–Danlos syndromes (2017) · cites this paper as Talhaoui et al., 2010

    The “Analysis of GAG Synthesis by Na₂[³⁵S]SO₄ Incorporation” methods section describes a biochemical assay for GAG synthesis, and the methods text on p. 37345 describes measuring total GAG synthesis. Both use cultured CHO cells, not patients’ fibroblasts; the paper does not establish that such testing is available in many specialized laboratories or that it provides definite proof of deficiency from both B4GALT7 and B3GALT6 mutations. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Quentin, E., Gladen, A., Rode ´n, L., and Kresse, H. (1990) Proc. Natl. Acad. Sci. U.S.A. 87, 1342-1346
  2. Belting, M., Borsig, L., Fuster, M. M., Brown, J. R., Persson, L., Fransson, L. A., and Esko, J. D. (2002) Proc. Natl. Acad. Sci. U.S.A. 99, 371-376
  3. Schuksz, M., Fuster, M. M., Brown, J. R., Crawford, B. E., Ditto, D. P., Lawrence, R., Glass, C. A., Wang, L., Tor, Y., and Esko, J. D. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 13075-13080
  4. DeAngelis, P. L., Jing, W., Drake, R. R., and Achyuthan, A. M. (1998) J. Biol. Chem. 273, 8454 -8458 ␤4GalT7 Key Functional Amino Acids 37358 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285 • NUMBER 48 • NOVEMBER 26, 2010

Cited by

Sorted by citations

Authors
Talhaoui, I., Bui, C., Oriol, R., Mulliert, G., Gulberti, S., Netter, P., Coughtrie, M. W. H., Ouzzine, M., & Fournel-Gigleux, S.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • University of Dundee (GB)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2010-11
Volume
285
Issue
48
Pages
37342-37358
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1987627048
Cited by
26
References
51
Citations by year
2026: 2 · 2024: 2 · 2021: 3 · 2020: 2 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 2
FWCI
1.30
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • University of Dundee
  • Agence Nationale de la Recherche (ANR-08-PCVI-0023)
  • Institut National de la Santé et de la Recherche Médicale
  • Centre National de la Recherche Scientifique
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
  • Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
Keywords
glycosaminoglycan synthesis, active site residues, enzyme kinetic properties, decorin, phylogenetic analysis
MeSH terms
Amino Acid Sequence, Animals, Galactosyltransferases, Glycosaminoglycans, Humans, Invertebrates, Models, Molecular, Molecular Sequence Data, Phylogeny, Substrate Specificity, Vertebrates, Sequence Alignment, Catalytic Domain, Amino Acid Motifs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review